SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences' arm to acquire 65% stake in Dresen Quimica

03 Feb 2016 Evaluate

Camlin Fine Sciences' subsidiary CFS Antioxidantes De Mexico S.A. DE C.V, Mexico (CFS Mexico) has entered into a share Purchase Agreements to acquire 65% stake in an entity in Mexico along with its proposed group companies, which shall be subject to certain conditions being fulfilled prior to the said acquisition. The target entity Dresen Quimica S.A.P.l.de C.V., Mexico (Dresen) is a medium sized company which is proposed to be acquired with its group companies (a condition precedent) means the Mexican entity Industries Petrotec de Mexico, S.A. de C.V.; the Peruvian company Nuvel, S.A.C.; the Guatemalan company Sritec, S.A., the Colombian company lnovel, S.A.S. and the Dominican Republic company Grinel, S.A. After the said acquisition, the company may expand its market reach in the North, Central and South America.

Dresen has large products portfolio, having proper sales mix with relevant processes and equipments in operation besides adequate installed capacity for operations to support future growth. It markets its products through its own sales force directed from its headquarters and its branches and a network of distributors in North, Central and South America.Camlin Fine is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).

Camlin Fine Sciences Share Price

126.97 4.00 (3.25%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3640.10
Tata Chemicals 809.45
SRF 2519.20
Pidilite Inds. 1375.55
Deepak Nitrite 1736.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×